General
Preferred name
COPTISINE
Synonyms
Q-100696 ()
NSC-119754 ()
Coptisin ()
Coptisine (Sulfate) ()
Coptisine (chloride) ()
COPTISINE CHLORIDE ()
Coptisine sulfate ()
Q-100696, NSC-119754 ()
Coptisine ()
P&D ID
PD087526
CAS
1198398-71-8
6020-18-4
3486-66-6
Tags
available
drug candidate
Drug Status
experimental
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Coptisine chloride is an alkaloid from Chinese goldthread, and acts as an efficient uncompetitive IDO inhibitor with a Ki value of 5.8 ¦ÌM and an IC50 value of 6.3 ¦ÌM. Coptisine chloride is a potent H1N1 neuraminidase (NA-1) inhibitor with an IC50 of 104.6 ¦Ìg/mL and can be used for influenza A (H1N1) infection.
PRICE
74
PRICE
98
PRICE
68
DESCRIPTION
1. Coptisine chloride (NSC-119754) can be absorbed across intestinal epithelial cells, and completely absorbed compounds.
(TargetMol Bioactive Compound Library)
DESCRIPTION
1. Coptisine (Coptisin) treatment increases cell viability based on its reversal effect on the enhanced activity of Indoleamine 2, 3-dioxygenase . 2. Coptisine treats myocardial I/R likely through suppressing myocardial apoptosis and inflammation by inhibiting the Rho/ROCK pathway. 3. Coptisine is a potential anti-osteosarcoma drug candidate, via exerting a strong anti-osteosarcoma effect with very low toxicity . 4. Coptisine with a high dosage could inhibit cholesterol synthesis via suppressing the HMGCR expression and promoting the use and excretion of cholesterol via up-regulating LDLR and CYP7A1 expression. 5. Coptisine suppresses adhesion, migration and invasion of MDA-MB-231 breast cancer cells in vitro, the down-regulation of MMP-9 in combination with the increase of TIMP-1 possibly contributing to the anti-metastatic function for breast cancer.
(TargetMol Bioactive Compound Library)
DESCRIPTION
1. Coptisine sulfate has growth inhibitory activity against human cancer cell line in the NCI's anticancer drug screening program.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
5
Organisms
0
Compound Sets
6
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
58
Molecular Weight
320.09
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
0
Rotatable Bonds
0
Ring Count
6
Aromatic Ring Count
3
cLogP
2.81
TPSA
40.8
Fraction CSP3
0.21
Chiral centers
0.0
Largest ring
6.0
QED
0.6
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Metabolic Enzyme/Protease
Cell Cycle/DNA Damage
cytoskeleton
Immunology/Inflammation
MAPK/ERK Pathway
PI3K/Akt/mTOR
Stem Cell/Wnt
TGF-beta/Smad
Anti-infection
Metabolism
Microbiology/virology
Target
Akt
Apoptosis
DNA/RNA Synthesis
Indoleamine 2,3-Dioxygenase (IDO)
LDLR
Mitochondrial Metabolism
NF-κB
p38 MAPK
PI3K
Reactive Oxygen Species (ROS)
ROCK
Bacterial
Influenza Virus
IDO
IDO/TDO
Source data

